Nebulised anti-pseudomonal antibiotics for cystic fibrosis - Wikidata - awgldk - TriplyDB

Nebulised anti-pseudomonal antibiotics for cystic fibrosis

Nebulised anti-pseudomonal antibiotics for cystic fibrosis

http://www.wikidata.org/entity/Q24247996

about

Q33909581 Q57692189

sameAs

Inhaled antibiotics for long-term therapy in cystic fibrosis Inhaled antibiotics for pulmonary exacerbations in cystic fibrosis Exacerbations in cystic fibrosis: 2 . prevention.Tobramycin inhalation powder for P. aeruginosa infection in cystic fibrosis: the EVOLVE trial.Management of refractory Pseudomonas aeruginosa infection in cystic fibrosis Evaluation of the Target Inhalation Mode (TIM) breathing maneuver in simulated nebulizer therapy in patients with cystic fibrosis.Comparative efficacy of two doses of nebulized colistimethate in the eradication of Pseudomonas aeruginosa in children with cystic fibrosis.A pilot study to compare tobramycin 80 mg injectable preparation with 300 mg solution for inhalation in cystic fibrosis patients Pegylation of antimicrobial peptides maintains the active peptide conformation, model membrane interactions, and antimicrobial activity while improving lung tissue biocompatibility following airway delivery.Nebulized Gentamicin as an Alternative to Nebulized Tobramycin for Tracheitis in Pediatric Patients.The costs of treatment of early and chronic Pseudomonas aeruginosa infection in cystic fibrosis patients.Shifting patterns of inhaled antibiotic use in cystic fibrosis.

P2860

Q24235635-75A73FC2-EF20-4BDC-983E-D2058D29FA48 Q24241270-B39FAD1F-3E05-4F0D-874B-D8182A04253C Q30480308-D2C5DCA9-BDA5-466C-8F5B-00947DBDAAB2 Q33957168-D86B875F-94B5-4BF4-A151-B0CB7049966E Q35026630-31CE7650-0500-40A7-947B-C77FC0FFFCF5 Q35049707-D49B2D1A-2455-4B2B-A646-7F3D984B165B Q37181232-E877F892-6D0E-4680-95F1-3E394D9A8A60 Q37185481-5E5918B6-A609-4DA0-AA6C-842B2357A140 Q39376740-ECF0D3B8-1A8D-42D2-8C4B-1282FE858412 Q40280569-3ABC264C-F954-4AD8-A276-8F8CDCAB69AA Q43489716-54BE00B9-5E7B-490E-B417-16D7A4177073 Q46453908-5A63C119-5CC9-471A-A671-94805F46D65A

P2860

Nebulised anti-pseudomonal antibiotics for cystic fibrosis

http://www.wikidata.org/entity/Q24247996

description

2003 nî lūn-bûn

@nan

2003 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2003 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2003年の論文

@ja

2003年論文

@yue

2003年論文

@zh-hant

2003年論文

@zh-hk

2003年論文

@zh-mo

2003年論文

@zh-tw

2003年论文

@wuu

name

Nebulised anti-pseudomonal antibiotics for cystic fibrosis

@ast

Nebulised anti-pseudomonal antibiotics for cystic fibrosis

@en

Nebulised anti-pseudomonal antibiotics for cystic fibrosis

@en-gb

Nebulised anti-pseudomonal antibiotics for cystic fibrosis

@nl

type

label

Nebulised anti-pseudomonal antibiotics for cystic fibrosis

@ast

Nebulised anti-pseudomonal antibiotics for cystic fibrosis

@en

Nebulised anti-pseudomonal antibiotics for cystic fibrosis

@en-gb

Nebulised anti-pseudomonal antibiotics for cystic fibrosis

@nl

altLabel

Nebulised anti-pseudomonal antibiotics for cystic fibrosis.

@en

prefLabel

Nebulised anti-pseudomonal antibiotics for cystic fibrosis

@ast

Nebulised anti-pseudomonal antibiotics for cystic fibrosis

@en

Nebulised anti-pseudomonal antibiotics for cystic fibrosis

@en-gb

Nebulised anti-pseudomonal antibiotics for cystic fibrosis

@nl

P1433

Q24247996-DF2A76BE-9550-4918-922E-CFF208566B02

P1476

Q24247996-394B0353-5820-47AE-87BB-D6FEF4A971AA

Q24247996-EE6E7EFB-CE1E-4970-800D-A7BCCAF412ED

P2093

Q24247996-2649BCEB-FEC9-4179-95B7-46B76BE1D5FF

Q24247996-7FF7AE06-F00E-4514-B372-210A5A1E36CB

Q24247996-A0A507C9-8AD9-4A08-8007-408C1C01C49D

Q24247996-C435BFFB-31F0-410D-89B9-6B590E3FA7FA

Q24247996-C7A861FA-87CA-400C-9469-EFDDFA610E17

Q24247996-F3D10C86-DBA3-4F52-ADCE-DD5E5F85BAA5

P2860

Q24247996-05B5A70F-D74F-4C25-9BBB-C9A2711D9862

Q24247996-081A141A-2D90-45F4-803B-6BEE37B50A8F

Q24247996-0E9F67CF-30FF-4CB0-8816-73E278C1D3C3

Q24247996-199E9A19-778F-4405-83E1-1CADDDCFEDE7

Q24247996-2E0695D1-6095-4A86-8059-52BDE245085F

Q24247996-479EBBAF-10F5-4679-8A2C-ECFDB442458E

Q24247996-492EE53E-C5AB-42E1-8111-C61F8C8713AD

Q24247996-4FA77CB8-0AD4-4F59-A520-7413C90B6324

Q24247996-55B98AE0-4CC2-4B36-8799-8B72B26F11A3

Q24247996-57A66907-FD21-4EE6-8AE5-027EA622D0C0

P304

Q24247996-3B96E803-68B3-4E63-9E7B-9BF182A0D5AD

P31

Q24247996-2D157F28-D93B-48EA-8D08-ACC537A4B71B

P356

Q24247996-D2B46D82-9418-4CC0-8AB1-611EDF459A1B

P407

Q24247996-9CDAE592-3813-49D9-A122-6AFFC6194712

P433

Q24247996-59E16850-30E0-49A5-B26A-923ED16D5180

Q24247996-AF9EE92A-FD04-404A-A4EC-0584401BD794

P577

Q24247996-4DA281CC-2A3F-46CC-9525-8ADB9B660B6E

Q24247996-596C426B-72A1-4AFB-8EE3-4CF2D16CA6E4

Q24247996-99EEEBEF-FEBC-42AD-AADC-BAA018C551B8

P698

Q24247996-25D19745-D561-4CF3-AF49-7CF5212F61C6

Q24247996-6F3D221B-EF4D-4C08-9074-59D87679CCB8

P921

Q24247996-7154C269-CE78-4971-89BA-130769C5BA8E

Q24247996-B9130037-71D0-4438-8F3D-789A8A68B8FE

P356

14651858.CD001021

P1433

Cochrane Database of Systematic Reviews

P1476

Nebulised anti-pseudomonal antibiotics for cystic fibrosis

@en

Nebulised anti-pseudomonal antibiotics for cystic fibrosis.

@en

P2093

G Ryan

http://www.w3.org/2001/XMLSchema#string

Gerard Ryan

http://www.w3.org/2001/XMLSchema#string

M Singh

http://www.w3.org/2001/XMLSchema#string

Meenu Singh

http://www.w3.org/2001/XMLSchema#string

S Mukhopadhyay

http://www.w3.org/2001/XMLSchema#string

Somnath Mukhopadhyay

http://www.w3.org/2001/XMLSchema#string

P2860

Nebulised hypertonic saline for cystic fibrosis

Measuring inconsistency in meta-analyses

Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials

Systematic reviews in health care: Assessing the quality of controlled clinical trials

Meta-analyses involving cross-over trials: methodological issues

Nebulised antipseudomonal antibiotic therapy in cystic fibrosis: a meta-analysis of benefits and risks.

Effect of aerosolized recombinant human DNase on exacerbations of respiratory symptoms and on pulmonary function in patients with cystic fibrosis. The Pulmozyme Study Group.

Effect of nebulized colistin sulphate and colistin sulphomethate on lung function in patients with cystic fibrosis: a pilot study.

Pharmacokinetics and bioavailability of aerosolized tobramycin in cystic fibrosis.

Effect of tonicity of nebulised colistin on chest tightness and pulmonary function in adults with cystic fibrosis.

P304

CD001021

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/14651858.CD001021

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

3

http://www.w3.org/2001/XMLSchema#string

P577

2000-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

2003-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

2003-07-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

10796732

http://www.w3.org/2001/XMLSchema#string

12917897

http://www.w3.org/2001/XMLSchema#string

P921

cystic fibrosis